158 related articles for article (PubMed ID: 38195541)
1. Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML).
Schittenhelm MM; Kaiser M; Győrffy B; Kampa-Schittenhelm KM
Cell Death Dis; 2024 Jan; 15(1):25. PubMed ID: 38195541
[TBL] [Abstract][Full Text] [Related]
2. Aspp1 Preserves Hematopoietic Stem Cell Pool Integrity and Prevents Malignant Transformation.
Yamashita M; Nitta E; Suda T
Cell Stem Cell; 2015 Jul; 17(1):23-34. PubMed ID: 26119234
[TBL] [Abstract][Full Text] [Related]
3. [Maintenance of hematopoietic stem cell integrity and regulation of leukemogenesis by p53 and its coactivator Aspp1].
Yamashita M; Nitta E; Suda T
Rinsho Ketsueki; 2015 Dec; 56(12):2426-33. PubMed ID: 26725350
[TBL] [Abstract][Full Text] [Related]
4. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
[TBL] [Abstract][Full Text] [Related]
5. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
Aylon Y; Ofir-Rosenfeld Y; Yabuta N; Lapi E; Nojima H; Lu X; Oren M
Genes Dev; 2010 Nov; 24(21):2420-9. PubMed ID: 21041410
[TBL] [Abstract][Full Text] [Related]
6. Interdependent Nuclear Co-Trafficking of ASPP1 and p53 Aggravates Cardiac Ischemia/Reperfusion Injury.
Yang Y; Zhang Y; Yang J; Zhang M; Tian T; Jiang Y; Liu X; Xue G; Li X; Zhang X; Li S; Huang X; Li Z; Guo Y; Zhao L; Bao H; Zhou Z; Song J; Yang G; Xuan L; Shan H; Zhang Z; Lu Y; Yang B; Pan Z
Circ Res; 2023 Jan; 132(2):208-222. PubMed ID: 36656967
[TBL] [Abstract][Full Text] [Related]
7. EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy.
Zhao K; Yu M; Zhu Y; Liu D; Wu Q; Hu Y
Cell Death Dis; 2017 Jun; 8(6):e2869. PubMed ID: 28594407
[TBL] [Abstract][Full Text] [Related]
8. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
[TBL] [Abstract][Full Text] [Related]
11. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
[TBL] [Abstract][Full Text] [Related]
12. ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo.
Wilson AM; Morquette B; Abdouh M; Unsain N; Barker PA; Feinstein E; Bernier G; Di Polo A
J Neurosci; 2013 Jan; 33(5):2205-16. PubMed ID: 23365256
[TBL] [Abstract][Full Text] [Related]
13. ASPP1 and ASPP2: common activators of p53 family members.
Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
[TBL] [Abstract][Full Text] [Related]
14. Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.
Schittenhelm MM; Illing B; Ahmut F; Rasp KH; Blumenstock G; Döhner K; Lopez CD; Kampa-Schittenhelm KM
PLoS One; 2013; 8(11):e80193. PubMed ID: 24312201
[TBL] [Abstract][Full Text] [Related]
15. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.
Fisser MC; Rommer A; Steinleitner K; Heller G; Herbst F; Wiese M; Glimm H; Sill H; Wieser R
Mol Carcinog; 2015 Dec; 54(12):1815-9. PubMed ID: 25491945
[TBL] [Abstract][Full Text] [Related]
16.
George B; Kantarjian H; Baran N; Krocker JD; Rios A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639121
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hematopoietic stem cell integrity through p53 and its related factors.
Yamashita M; Nitta E; Suda T
Ann N Y Acad Sci; 2016 Apr; 1370(1):45-54. PubMed ID: 26695737
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.
Wang Y; Liu Y; Bailey C; Zhang H; He M; Sun D; Zhang P; Parkin B; Baer MR; Zheng P; Malek SN; Liu Y
Oncogene; 2020 Apr; 39(14):3015-3027. PubMed ID: 32060420
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
20. AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.
Yan B; Claxton D; Huang S; Qiu Y
Exp Hematol; 2020 Jul; 87():13-19. PubMed ID: 32569759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
